Houttuynia cordata Extract Improves Physical Endurance Performance by Regulating Endothelial Production of Nitric Oxide.
Vascular function is mediated by various regulatory molecules, including endothelial nitric oxide (NO), which regulates the vasodilation of smooth muscle cells. We investigated whether standardized Houttuynia cordata extract (SHCE) could improve physical endurance performance by regulating the endothelial production of NO. For the standardization of Houttuynia cordata (HC) extract, its bioactive components were identified and quantified using ultraperformance liquid chromatography-mass spectrometry. Bioaccessibility and biological activity were measured by the in vitro digestion model system and free radical scavenging capacity, respectively. The vascular function in the endothelium was assessed by the phosphorylation of endothelial nitric oxide synthase (eNOS). A preliminary clinical trial was carried out to assess the physical endurance performance. HC extract was standardized to bioactive components, including chlorogenic acid, rutin, and quercitrin, with the concentration of 5.53, 6.09, and 16.15 mg from 1 g of dry weight, respectively. Bioaccessibility was 33.17%, 31.67%, and 11.18% for chlorogenic acid, rutin, and quercitrin, respectively. Antioxidant activities of SHCE were expressed as vitamin C equivalent antioxidant capacity in 55.81 and 17.23 mg/g of HC extract using ABTS and DPPH scavenging assay, respectively. In human aortic endothelial cells, insulin-mediated phosphorylation of eNOS was increased by SHCE in the presence of palmitate. However, the expression of blood pressure-regulating genes was not altered. The level of blood lactate concentration and the heart rate of subjects who drank SHCE were lower than those of subjects who drank plain water. Oxygen uptake from subjects drinking SHCE was slightly higher than that from those who drank plain water. This study demonstrated that SHCE decreased heart rate and blood lactate, increased oxygen uptake, and improved physical performance, presumably due to the increased NO production.
1 Department of Food Science and Technology, Sejong University , Seoul, Korea.
Ui-Jeong
UJ
Yang
2 Department of Life Science, Gachon University , Gyeonggi, Korea.
Hyojin
H
Maeng
2 Department of Life Science, Gachon University , Gyeonggi, Korea.
Tae-Sik
TS
Park
1 Department of Food Science and Technology, Sejong University , Seoul, Korea.
Soon-Mi
SM
Shim
D000975:Antioxidants / Q000032:analysis / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002726:Chlorogenic Acid / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology; D004365:Drugs, Chinese Herbal / Q000737:chemistry / Q000494:pharmacology*; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism; D006339:Heart Rate / Q000187:drug effects; D052859:Houttuynia / Q000737:chemistry*; D006801:Humans; D019344:Lactic Acid / Q000097:blood; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010766:Phosphorylation; D010807:Physical Endurance / Q000187:drug effects* / Q000502:physiology; D011794:Quercetin / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology; D012431:Rutin / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology; D015398:Signal Transduction; D014664:Vasodilation
D000975:Antioxidants; D004365:Drugs, Chinese Herbal; C442781:Houttuynia cordata extract; D002726:Chlorogenic Acid; D009569:Nitric Oxide; D019344:Lactic Acid; D012431:Rutin; D011794:Quercetin; D052250:Nitric Oxide Synthase Type III
Houttuynia cordata; nitric oxide; physical endurance performance; standardization